Want to see MDLN full AI Analyst Report?
MDLN Stock Chart & Stats
$47.64
--
Market closed
$47.64
--
Day’s Range― - ―
52-Week Range$32.82 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)11.14M
Market Cap
$53.66B
Enterprise Value$41.20B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$12.64B
Price to Earnings (P/E)33.8
Beta1.12
Next Earnings
Aug 05, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding845,606,200
10 Day Avg. Volume9,011,099
30 Day Avg. Volume11,144,248
Financial Highlights & Ratios
PEG Ratio-4.96
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio26.29
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue1.41
Enterprise Value/Gross Profit5.88
Enterprise Value/Ebitda15.09
Forecast
1Y Price Target
$51.24Price Target Upside7.55% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)1.51
Revenue Forecast (FY)$31.09B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Improving Gross MarginSustained revenue scaling together with a multi-year gross margin improvement implies stronger pricing, better mix and operating leverage. These structural trends support durable operating cash flow expansion and provide room to invest in distribution or product breadth over the next 2–6 months.
Steady Cash Generation And Improving FCFConsistent operating cash flow and a meaningful improvement in free cash flow in 2025 indicate the business converts revenue into cash reliably. That persistent cash generation underpins debt servicing, capex and strategic investments, increasing financial resilience over the medium term.
Refinancing Extends Debt MaturitiesThe completed refinancing replaces near-term maturities with longer-dated secured notes and a 2033 term loan, reducing near-term refinancing pressure. Extending maturities and consolidating facilities materially improves liquidity runway and gives management time to delever or execute strategy.
Bears Say
Meaningful LeverageLeverage around or above 1x equity materially constrains flexibility: higher interest and covenant exposure reduce capacity for opportunistic investment, increase refinancing sensitivity, and can amplify earnings pressure if sales or margins weaken over the coming months.
Margin Volatility And Net Margin CompressionDespite gross margin gains, net and operating margins have shown volatility and recent compression, indicating cost or SG&A pressures. Persistent volatility means revenue growth may not reliably translate to profit, complicating forecasting and limiting sustainable free cash flow expansion.
COO Retirement And Operations Leadership RiskA planned COO departure for health reasons creates a leadership transition during a period of active refinancing and operational execution. Replacing operational leadership risks short-term continuity in supply chain, margin initiatives and integration projects, and could slow implementation of strategic plans.
Medline News
MDLN FAQ
What was Medline, Inc. Class A’s price range in the past 12 months?
Medline, Inc. Class A lowest stock price was $32.81 and its highest was $50.88 in the past 12 months.
What is Medline, Inc. Class A’s market cap?
Medline, Inc. Class A’s market cap is $53.66B.
When is Medline, Inc. Class A’s upcoming earnings report date?
Medline, Inc. Class A’s upcoming earnings report date is Aug 05, 2026 which is in 25 days.
How were Medline, Inc. Class A’s earnings last quarter?
Medline, Inc. Class A released its earnings results on May 06, 2026. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.295 by $0.035.
Is Medline, Inc. Class A overvalued?
According to Wall Street analysts Medline, Inc. Class A’s price is currently Undervalued.
Does Medline, Inc. Class A pay dividends?
Medline, Inc. Class A does not currently pay dividends.
What is Medline, Inc. Class A’s EPS estimate?
Medline, Inc. Class A’s EPS estimate is 0.32.
How many shares outstanding does Medline, Inc. Class A have?
Medline, Inc. Class A has 845,606,200 shares outstanding.
What happened to Medline, Inc. Class A’s price movement after its last earnings report?
Medline, Inc. Class A reported an EPS of $0.33 in its last earnings report, beating expectations of $0.295. Following the earnings report the stock price went down -7.304%.
Which hedge fund is a major shareholder of Medline, Inc. Class A?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$51.24 (7.55% Upside)
$51.24 (7.55% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 7.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Company Description
Medline, Inc. Class A
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
MDLN Company Deck
MDLN Earnings Call
Q1 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$51.24
▲(7.55% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―